| Real-world evidence in Asia Pacific: Are we ready? Challenges and novel
approaches to generating evidence in the absence of real-world data |
| Author(s): Willford J1, Eggleston A2, Caputo J1 |
| Affiliations(s): 1 IMS Health Asia Pacific, Singapore 2 Sanofi, Singapore |
| Publication(s): ISPOR 17th Annual European Congress, 8th – 12th November 2014, Amsterdam |
| Document Type(s): Symposium |
| Countries: Asia Pacific |
C:
Y: |
Methodology
2014 |
|
L:
A: |
English
Real World Data |
|
 |
| |
| |
| Real-world evidence in Asia-Pacific: are we ready? Challenges and novel approaches to generating evidence in the absence of real-world data |
| Author(s): Willford J1, Eggleston A2, Caputo J1 |
| Affiliations(s): 1 IMS Health Asia Pacific, Singapore 2 Sanofi, Singapore |
| Publication(s): ISPOR 6th Asia-Pacific Conference, Beijing, China, 6-9 September, 2014 |
| Document Type(s): Poster |
| Countries: Asia Pacific |
C:
Y: |
Methodology
2014 |
|
L:
A: |
English
Real World Evidence |
|
|
| |
| |
| Envisioning oncology coverage decision framework: how do current and future trends in Asia-Pacific affect the accessibility? |
| Author(s): Leartsakulpanitch J1, Chiu C-F2, Bae SJ3, Tan SC4 |
| Affiliations(s): 1 Johnson & Johnson, Bangkok, Thailand 2 China Medical University Hospital, Taipei, Taiwan 3 Ewha Womans University, Seoul, South Korea 4 IMS Asia Pacific, Singapore, Singapore |
| Publication(s): ISPOR 6th Asia-Pacific Conference, Beijing, China, 6-9 September, 2014 |
| Document Type(s): Symposium |
| Countries: Asia Pacific |
C:
Y: |
Oncology
2014 |
|
L:
A: |
English
Methodology |
|
|
| |
| |
| Understanding treatment in metastatic castrate-resistant prostate cancer: Implications of variance between UK and Asia |
| Author(s): King C |
| Affiliations(s): IMS Health Asia-Pac & China, Singapore |
| Publication(s): AccessPoint, 2014, May; 4(8): 36-39 |
| Document Type(s): Article |
| Countries: Asia Pacific, UK |
| Click here for the abstract |
C:
Y: |
Oncology
2014 |
|
L:
A: |
English
Real World Evidence |
|
|
| |
| |
| High-value oncology targeted therapies: Opportunities and challenges in emerging Asia Pacific markets |
| Author(s): Afable A, Caputo J |
| Affiliations(s): IMS Health, Asia-Pac, Singapore, Singapore |
| Publication(s): AccessPoint, 2014, May; 4(8): 46-50 |
| Document Type(s): Article |
| Countries: Asia Pacific |
| Click here for the abstract |
C:
Y: |
Oncology, Pricing and reimbursement
2014 |
|
L:
A: |
English
Real World Evidence |
|
|
| |
| |
| Conducting outcomes research using electronic databases in Asia Pacific |
| Author(s): Chaiyakunapruk N1, Chiou C-F2, Crawford B3 |
| Affiliations(s): 1 Monash University Malaysia, Selangor, Malaysia 2 Janssen Asia Pacific, Singapore, Singapore 3 Real World Evidence Solutions, Japan & APAC, IMS Health KK, Tokyo, Japan |
| Publication(s): ISPOR 6th Asia-Pacific Conference, Beijing, China, 6-9 September, 2014 |
| Document Type(s): Workshop |
| Countries: Asia Pacific |
C:
Y: |
Methodology
2014 |
|
L:
A: |
English
Real World Data |
|
|
| |
| |
| Real World Evidence: Meeting the challenge of stakeholder needs for demonstrating value in Asia |
| Author(s): Nelson M1, Ngorsuraches S2, Caputo J3 |
| Affiliations(s): 1 IMS Health, Alexandria, US 2 Prince of Songkla University, Songkla, Thailand 3 IMS Health, Singapore |
| Publication(s): ISPOR 5th Asia-Pacific Conference, Taipei, Taiwan, September 2nd – 4th 2012 |
| Document Type(s): Podium presentation |
| Countries: Asia Pacific |
C:
Y: |
Pricing and reimbursement
2012 |
|
L:
A: |
English
Pricing & Reimbursement |
|
|
| |
| |
| Conducting Real-World Studies in emerging Asian markets |
| Author(s): Lara N1, Caputo J2, Lai H-J3, Yin-Yin Huang G4 |
| Affiliations(s): 1 IMS Health, Barcelona, Spain 2 IMS Health, Singapore, Singapore 3 Merck, Sharp & Dohme Corp., Taipei, Taiwan 4 IMS Health, Taipei, Taiwan |
| Publication(s): ISPOR 5th Asia-Pacific Conference, Taipei, Taiwan, September 2nd – 4th 2012 |
| Document Type(s): Workshop |
| Countries: Asia Pacific |
| Click here for the abstract |
C:
Y: |
Pricing and reimbursement
2012 |
|
L:
A: |
English
Workshop |
|
|
| |
| |
| Hepatitis C virus in Asia: utility values based on the Short Form-36 questionnaire. |
| Author(s): Crawford B 1, Yeung CK 1, Tanaka E 1, Kraemer M 2, Leteneux C2. |
| Affiliations(s): 1. Adelphi Values, Arco Tower 12F, 1-8-1 Shimomeguro, Meguro-ku, Tokyo 153-0064, Japan
2. Novartis Pharmaceuticals, Novartis Campus, Fabrikstr. 6-5. 09.2, CH-4056 Basel, Switzerland |
| Publication(s): Expert Rev Pharmacoecon Outcomes Res. 2012 Dec;12(6):765-73. doi: 10.1586/erp.12.61. |
| Document Type(s): Article |
| Countries: Asia Pacific |
| Click here for the abstract |
C:
Y: |
Infectious disease, Methodology
2012 |
|
L:
A: |
English
Survey research |
|
|
| |
| |
| USING MAPPED EQ-5D FROM DISEASE-SPECIFIC MEASURES IN COST-UTILITY ANALYSIS: WHAT IS THE CURRENT STATE IN ASIA PACIFIC? |
| Author(s): Leartsakulpanitch J, Crawford B, Lee EK, Chiou CF. |
| Affiliations(s): |
| Publication(s): ISPOR 5th Asia-Pacific Conference
Taipei International Convention Center, Taiwan
September 4th, 2012 |
| Document Type(s): Poster |
| Countries: Asia Pacific |
| Click here for the abstract |
C:
Y: |
Methodology
2012 |
|
L:
A: |
English
|
|
|
| |
| |
 1 of 2 
|
